Loading...
XASX
MVF
Market cap203mUSD
Oct 09, Last price  
0.75AUD
1D
-0.67%
1Q
4.20%
Jan 2017
-63.66%
IPO
-58.61%
Name

Monash IVF Group Ltd

Chart & performance

D1W1MN
XASX:MVF chart
P/E
39.09
P/S
1.08
EPS
0.02
Div yield, %
6.93%
Shrs. gr., 5y
—
Rev. gr., 5y
7.97%
Revenues
269m
-0.90%
96,598,000114,012,000124,955,000156,561,000155,182,000150,638,000151,980,000145,417,000183,605,000192,294,000213,590,000254,960,000271,917,000269,459,000
Net income
7m
-70.31%
-14,856,0002,581,00021,373,00028,775,00029,619,00021,353,00019,852,00011,726,00025,148,00018,406,00021,839,000-6,527,00025,008,0007,425,000
CFO
30m
+134.11%
30,106,00036,222,00036,008,00044,162,00025,909,00025,930,00033,093,00026,542,00043,254,00031,276,00037,952,00052,519,00012,902,00030,205,000
Dividend
Sep 03, 20260.013 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care. This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.

Key people

Josef Jerzy Czyzewski
Independent Non-Executive Director · since 2014
Independent Non-Executive Director · since 2016
IPO date
Jun 26, 2014
Employees
867
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT